Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.24 USD | -0.90% | +15.81% | +19.13% |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
Apr. 25 | Leerink Partners Upgrades Tandem Diabetes Care to Outperform Rating, Price Target is $45 | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Neutral |
Resistance | 35.56 | 35.56 | 35.67 |
Spread/Res. | -0.90% | -0.90% | -1.21% |
Spread/Supp. | +6.24% | +56.27% | +146.78% |
Support | 33.17 | 22.55 | 14.28 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- TNDM Stock
- Charts Tandem Diabetes Care, Inc.